Sort   by:  
 Page size 
UnknownOperational complexity versus design efficiency: challenges of implementing a phase IIa multiple parallel cohort targeted treatment platform trial in advanced breast cancer.
Not available
S-EPMC9077636 | biostudies-literature
UnknownComplete Genome and Plasmid Sequences of 32 Salmonella enterica Strains from 30 Serovars.
Not available
S-EPMC6256492 | biostudies-literature
UnknownComplete Genome Sequences for 36 Canadian Salmonella enterica Serovar Typhimurium and I 1,4,[5],12:i:- Isolates from Clinical and Animal Sources.
Not available
S-EPMC8407683 | biostudies-literature
UnknownAssessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in triple negative breast cancer: the TNT trial.
Not available
S-EPMC7784666 | biostudies-literature
UnknownIntegrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727).
Not available
S-EPMC10502473 | biostudies-literature
UnknownGenomic profile of advanced breast cancer in circulating tumour DNA.
Not available
S-EPMC8065112 | biostudies-literature
UnknownCediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.
Not available
S-EPMC6602919 | biostudies-literature
UnknownCirculating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.
Not available
S-EPMC7599319 | biostudies-literature
UnknownPractical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units.
Not available
S-EPMC9449272 | biostudies-literature
UnknownCarboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.
Not available
S-EPMC6372067 | biostudies-literature
Sort   by:  
 Page size